Pharmafile Logo

Dedicated

UK flag

UK plans to reduce use of animals in research

Looks to new technologies to screen earlier for drug failures

Sanofi reception

Sanofi has been light on product launches, says CEO

Drugs launched since 2009 contribute less than €1bn to 2013 turnover

- PMLiVE

Roche blocks Herceptin biosimilar in India

Wins court battle after claiming Biocon and Mylan had not followed regulatory criteria

- PMLiVE

What a traffic jam taught me…

Non-traditional ideas could be brought to bear to increase access to healthcare services

- PMLiVE

Cipher names Gerald McDole as chair

He has experience at AstraZeneca

- PMLiVE

RBW Consulting appoints researcher

Emma-Jane Lawson joins recruitment firm

- PMLiVE

Shire’s ADHD drug fails in depression trial

Company drops Vyvanse for use in major depressive disorder

- PMLiVE

AbbVie unveils its first Asian manufacturing plant

$320m facility set for Singapore

- PMLiVE

Soriot says pipeline will speed recovery at AZ

Diabetes franchise among new products expected to return company to growth

- PMLiVE

Digital strategy and maximising its impact

Digital channels continue to be a key focus for 2014, but as pharma continues to look ahead to a digital future is there more we can be doing to enhance...

aTyr appoints rare disease expert as president

Frederic Chereau has senior experience at Shire and Genzyme

- PMLiVE

Orphan drugs: A ‘responsible’ investment

There's growing sense of responsibility in the orphan drug market, but the market remains under-exploited by companies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links